Global Mucopolysaccharidosis (MPS) Treatment Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Mucopolysaccharidoses are a group of metabolic disorders caused by the absence or malfunctioning of lysosomal enzymes needed to break down molecules called glycosaminoglycans. These long chains of sugar carbohydrates occur within the cells that help build bone, cartilage, tendons, corneas, skin and connective tissue. Glycosaminoglycans (formerly called mucopolysaccharides) are also found in the fluids that lubricate joints.
LPI (LP Information)' newest research report, the “Mucopolysaccharidosis (MPS) Treatment Industry Forecast” looks at past sales and reviews total world Mucopolysaccharidosis (MPS) Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Mucopolysaccharidosis (MPS) Treatment sales for 2023 through 2029. With Mucopolysaccharidosis (MPS) Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mucopolysaccharidosis (MPS) Treatment industry.
This Insight Report provides a comprehensive analysis of the global Mucopolysaccharidosis (MPS) Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mucopolysaccharidosis (MPS) Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Mucopolysaccharidosis (MPS) Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mucopolysaccharidosis (MPS) Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mucopolysaccharidosis (MPS) Treatment.
The global Mucopolysaccharidosis (MPS) Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Mucopolysaccharidosis (MPS) Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Mucopolysaccharidosis (MPS) Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Mucopolysaccharidosis (MPS) Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Mucopolysaccharidosis (MPS) Treatment players cover Sanofi, Shire (Takeda), BioMarin Pharmaceutical, Esteve, REGENXBIO Inc, Sangamo Therapeutics, Ultragenyx Pharmaceutical, Abeona Therapeutics and ArmaGen, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Mucopolysaccharidosis (MPS) Treatment market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Mucopolysaccharidoses are a group of metabolic disorders caused by the absence or malfunctioning of lysosomal enzymes needed to break down molecules called glycosaminoglycans. These long chains of sugar carbohydrates occur within the cells that help build bone, cartilage, tendons, corneas, skin and connective tissue. Glycosaminoglycans (formerly called mucopolysaccharides) are also found in the fluids that lubricate joints.
LPI (LP Information)' newest research report, the “Mucopolysaccharidosis (MPS) Treatment Industry Forecast” looks at past sales and reviews total world Mucopolysaccharidosis (MPS) Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Mucopolysaccharidosis (MPS) Treatment sales for 2023 through 2029. With Mucopolysaccharidosis (MPS) Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mucopolysaccharidosis (MPS) Treatment industry.
This Insight Report provides a comprehensive analysis of the global Mucopolysaccharidosis (MPS) Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mucopolysaccharidosis (MPS) Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Mucopolysaccharidosis (MPS) Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mucopolysaccharidosis (MPS) Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mucopolysaccharidosis (MPS) Treatment.
The global Mucopolysaccharidosis (MPS) Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Mucopolysaccharidosis (MPS) Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Mucopolysaccharidosis (MPS) Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Mucopolysaccharidosis (MPS) Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Mucopolysaccharidosis (MPS) Treatment players cover Sanofi, Shire (Takeda), BioMarin Pharmaceutical, Esteve, REGENXBIO Inc, Sangamo Therapeutics, Ultragenyx Pharmaceutical, Abeona Therapeutics and ArmaGen, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Mucopolysaccharidosis (MPS) Treatment market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Stem Cell Therapies
- Enzyme Replacement Therapies
- Hospitals
- Clinics
- Homecare
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi
- Shire (Takeda)
- BioMarin Pharmaceutical
- Esteve
- REGENXBIO Inc
- Sangamo Therapeutics
- Ultragenyx Pharmaceutical
- Abeona Therapeutics
- ArmaGen
- Eloxx Pharmaceuticals
- Inventiva
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Mucopolysaccharidosis (MPS) Treatment Market Size 2018-2029
2.1.2 Mucopolysaccharidosis (MPS) Treatment Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Mucopolysaccharidosis (MPS) Treatment Segment by Type
2.2.1 Stem Cell Therapies
2.2.2 Enzyme Replacement Therapies
2.3 Mucopolysaccharidosis (MPS) Treatment Market Size by Type
2.3.1 Mucopolysaccharidosis (MPS) Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Type (2018-2023)
2.4 Mucopolysaccharidosis (MPS) Treatment Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Homecare
2.5 Mucopolysaccharidosis (MPS) Treatment Market Size by Application
2.5.1 Mucopolysaccharidosis (MPS) Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Application (2018-2023)
3 MUCOPOLYSACCHARIDOSIS (MPS) TREATMENT MARKET SIZE BY PLAYER
3.1 Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Players
3.1.1 Global Mucopolysaccharidosis (MPS) Treatment Revenue by Players (2018-2023)
3.1.2 Global Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Mucopolysaccharidosis (MPS) Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 MUCOPOLYSACCHARIDOSIS (MPS) TREATMENT BY REGIONS
4.1 Mucopolysaccharidosis (MPS) Treatment Market Size by Regions (2018-2023)
4.2 Americas Mucopolysaccharidosis (MPS) Treatment Market Size Growth (2018-2023)
4.3 APAC Mucopolysaccharidosis (MPS) Treatment Market Size Growth (2018-2023)
4.4 Europe Mucopolysaccharidosis (MPS) Treatment Market Size Growth (2018-2023)
4.5 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2018-2023)
5.2 Americas Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2018-2023)
5.3 Americas Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mucopolysaccharidosis (MPS) Treatment Market Size by Region (2018-2023)
6.2 APAC Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2018-2023)
6.3 APAC Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Mucopolysaccharidosis (MPS) Treatment by Country (2018-2023)
7.2 Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2018-2023)
7.3 Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment by Region (2018-2023)
8.2 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2018-2023)
8.3 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL MUCOPOLYSACCHARIDOSIS (MPS) TREATMENT MARKET FORECAST
10.1 Global Mucopolysaccharidosis (MPS) Treatment Forecast by Regions (2024-2029)
10.1.1 Global Mucopolysaccharidosis (MPS) Treatment Forecast by Regions (2024-2029)
10.1.2 Americas Mucopolysaccharidosis (MPS) Treatment Forecast
10.1.3 APAC Mucopolysaccharidosis (MPS) Treatment Forecast
10.1.4 Europe Mucopolysaccharidosis (MPS) Treatment Forecast
10.1.5 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Forecast
10.2 Americas Mucopolysaccharidosis (MPS) Treatment Forecast by Country (2024-2029)
10.2.1 United States Mucopolysaccharidosis (MPS) Treatment Market Forecast
10.2.2 Canada Mucopolysaccharidosis (MPS) Treatment Market Forecast
10.2.3 Mexico Mucopolysaccharidosis (MPS) Treatment Market Forecast
10.2.4 Brazil Mucopolysaccharidosis (MPS) Treatment Market Forecast
10.3 APAC Mucopolysaccharidosis (MPS) Treatment Forecast by Region (2024-2029)
10.3.1 China Mucopolysaccharidosis (MPS) Treatment Market Forecast
10.3.2 Japan Mucopolysaccharidosis (MPS) Treatment Market Forecast
10.3.3 Korea Mucopolysaccharidosis (MPS) Treatment Market Forecast
10.3.4 Southeast Asia Mucopolysaccharidosis (MPS) Treatment Market Forecast
10.3.5 India Mucopolysaccharidosis (MPS) Treatment Market Forecast
10.3.6 Australia Mucopolysaccharidosis (MPS) Treatment Market Forecast
10.4 Europe Mucopolysaccharidosis (MPS) Treatment Forecast by Country (2024-2029)
10.4.1 Germany Mucopolysaccharidosis (MPS) Treatment Market Forecast
10.4.2 France Mucopolysaccharidosis (MPS) Treatment Market Forecast
10.4.3 UK Mucopolysaccharidosis (MPS) Treatment Market Forecast
10.4.4 Italy Mucopolysaccharidosis (MPS) Treatment Market Forecast
10.4.5 Russia Mucopolysaccharidosis (MPS) Treatment Market Forecast
10.5 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Forecast by Region (2024-2029)
10.5.1 Egypt Mucopolysaccharidosis (MPS) Treatment Market Forecast
10.5.2 South Africa Mucopolysaccharidosis (MPS) Treatment Market Forecast
10.5.3 Israel Mucopolysaccharidosis (MPS) Treatment Market Forecast
10.5.4 Turkey Mucopolysaccharidosis (MPS) Treatment Market Forecast
10.5.5 GCC Countries Mucopolysaccharidosis (MPS) Treatment Market Forecast
10.6 Global Mucopolysaccharidosis (MPS) Treatment Forecast by Type (2024-2029)
10.7 Global Mucopolysaccharidosis (MPS) Treatment Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Mucopolysaccharidosis (MPS) Treatment Product Offered
11.1.3 Sanofi Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 Shire (Takeda)
11.2.1 Shire (Takeda) Company Information
11.2.2 Shire (Takeda) Mucopolysaccharidosis (MPS) Treatment Product Offered
11.2.3 Shire (Takeda) Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Shire (Takeda) Main Business Overview
11.2.5 Shire (Takeda) Latest Developments
11.3 BioMarin Pharmaceutical
11.3.1 BioMarin Pharmaceutical Company Information
11.3.2 BioMarin Pharmaceutical Mucopolysaccharidosis (MPS) Treatment Product Offered
11.3.3 BioMarin Pharmaceutical Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 BioMarin Pharmaceutical Main Business Overview
11.3.5 BioMarin Pharmaceutical Latest Developments
11.4 Esteve
11.4.1 Esteve Company Information
11.4.2 Esteve Mucopolysaccharidosis (MPS) Treatment Product Offered
11.4.3 Esteve Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Esteve Main Business Overview
11.4.5 Esteve Latest Developments
11.5 REGENXBIO Inc
11.5.1 REGENXBIO Inc Company Information
11.5.2 REGENXBIO Inc Mucopolysaccharidosis (MPS) Treatment Product Offered
11.5.3 REGENXBIO Inc Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 REGENXBIO Inc Main Business Overview
11.5.5 REGENXBIO Inc Latest Developments
11.6 Sangamo Therapeutics
11.6.1 Sangamo Therapeutics Company Information
11.6.2 Sangamo Therapeutics Mucopolysaccharidosis (MPS) Treatment Product Offered
11.6.3 Sangamo Therapeutics Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Sangamo Therapeutics Main Business Overview
11.6.5 Sangamo Therapeutics Latest Developments
11.7 Ultragenyx Pharmaceutical
11.7.1 Ultragenyx Pharmaceutical Company Information
11.7.2 Ultragenyx Pharmaceutical Mucopolysaccharidosis (MPS) Treatment Product Offered
11.7.3 Ultragenyx Pharmaceutical Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Ultragenyx Pharmaceutical Main Business Overview
11.7.5 Ultragenyx Pharmaceutical Latest Developments
11.8 Abeona Therapeutics
11.8.1 Abeona Therapeutics Company Information
11.8.2 Abeona Therapeutics Mucopolysaccharidosis (MPS) Treatment Product Offered
11.8.3 Abeona Therapeutics Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Abeona Therapeutics Main Business Overview
11.8.5 Abeona Therapeutics Latest Developments
11.9 ArmaGen
11.9.1 ArmaGen Company Information
11.9.2 ArmaGen Mucopolysaccharidosis (MPS) Treatment Product Offered
11.9.3 ArmaGen Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 ArmaGen Main Business Overview
11.9.5 ArmaGen Latest Developments
11.10 Eloxx Pharmaceuticals
11.10.1 Eloxx Pharmaceuticals Company Information
11.10.2 Eloxx Pharmaceuticals Mucopolysaccharidosis (MPS) Treatment Product Offered
11.10.3 Eloxx Pharmaceuticals Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Eloxx Pharmaceuticals Main Business Overview
11.10.5 Eloxx Pharmaceuticals Latest Developments
11.11 Inventiva
11.11.1 Inventiva Company Information
11.11.2 Inventiva Mucopolysaccharidosis (MPS) Treatment Product Offered
11.11.3 Inventiva Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Inventiva Main Business Overview
11.11.5 Inventiva Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Mucopolysaccharidosis (MPS) Treatment Market Size 2018-2029
2.1.2 Mucopolysaccharidosis (MPS) Treatment Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Mucopolysaccharidosis (MPS) Treatment Segment by Type
2.2.1 Stem Cell Therapies
2.2.2 Enzyme Replacement Therapies
2.3 Mucopolysaccharidosis (MPS) Treatment Market Size by Type
2.3.1 Mucopolysaccharidosis (MPS) Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Type (2018-2023)
2.4 Mucopolysaccharidosis (MPS) Treatment Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Homecare
2.5 Mucopolysaccharidosis (MPS) Treatment Market Size by Application
2.5.1 Mucopolysaccharidosis (MPS) Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Application (2018-2023)
3 MUCOPOLYSACCHARIDOSIS (MPS) TREATMENT MARKET SIZE BY PLAYER
3.1 Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Players
3.1.1 Global Mucopolysaccharidosis (MPS) Treatment Revenue by Players (2018-2023)
3.1.2 Global Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Mucopolysaccharidosis (MPS) Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 MUCOPOLYSACCHARIDOSIS (MPS) TREATMENT BY REGIONS
4.1 Mucopolysaccharidosis (MPS) Treatment Market Size by Regions (2018-2023)
4.2 Americas Mucopolysaccharidosis (MPS) Treatment Market Size Growth (2018-2023)
4.3 APAC Mucopolysaccharidosis (MPS) Treatment Market Size Growth (2018-2023)
4.4 Europe Mucopolysaccharidosis (MPS) Treatment Market Size Growth (2018-2023)
4.5 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2018-2023)
5.2 Americas Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2018-2023)
5.3 Americas Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mucopolysaccharidosis (MPS) Treatment Market Size by Region (2018-2023)
6.2 APAC Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2018-2023)
6.3 APAC Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Mucopolysaccharidosis (MPS) Treatment by Country (2018-2023)
7.2 Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2018-2023)
7.3 Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment by Region (2018-2023)
8.2 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2018-2023)
8.3 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL MUCOPOLYSACCHARIDOSIS (MPS) TREATMENT MARKET FORECAST
10.1 Global Mucopolysaccharidosis (MPS) Treatment Forecast by Regions (2024-2029)
10.1.1 Global Mucopolysaccharidosis (MPS) Treatment Forecast by Regions (2024-2029)
10.1.2 Americas Mucopolysaccharidosis (MPS) Treatment Forecast
10.1.3 APAC Mucopolysaccharidosis (MPS) Treatment Forecast
10.1.4 Europe Mucopolysaccharidosis (MPS) Treatment Forecast
10.1.5 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Forecast
10.2 Americas Mucopolysaccharidosis (MPS) Treatment Forecast by Country (2024-2029)
10.2.1 United States Mucopolysaccharidosis (MPS) Treatment Market Forecast
10.2.2 Canada Mucopolysaccharidosis (MPS) Treatment Market Forecast
10.2.3 Mexico Mucopolysaccharidosis (MPS) Treatment Market Forecast
10.2.4 Brazil Mucopolysaccharidosis (MPS) Treatment Market Forecast
10.3 APAC Mucopolysaccharidosis (MPS) Treatment Forecast by Region (2024-2029)
10.3.1 China Mucopolysaccharidosis (MPS) Treatment Market Forecast
10.3.2 Japan Mucopolysaccharidosis (MPS) Treatment Market Forecast
10.3.3 Korea Mucopolysaccharidosis (MPS) Treatment Market Forecast
10.3.4 Southeast Asia Mucopolysaccharidosis (MPS) Treatment Market Forecast
10.3.5 India Mucopolysaccharidosis (MPS) Treatment Market Forecast
10.3.6 Australia Mucopolysaccharidosis (MPS) Treatment Market Forecast
10.4 Europe Mucopolysaccharidosis (MPS) Treatment Forecast by Country (2024-2029)
10.4.1 Germany Mucopolysaccharidosis (MPS) Treatment Market Forecast
10.4.2 France Mucopolysaccharidosis (MPS) Treatment Market Forecast
10.4.3 UK Mucopolysaccharidosis (MPS) Treatment Market Forecast
10.4.4 Italy Mucopolysaccharidosis (MPS) Treatment Market Forecast
10.4.5 Russia Mucopolysaccharidosis (MPS) Treatment Market Forecast
10.5 Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Forecast by Region (2024-2029)
10.5.1 Egypt Mucopolysaccharidosis (MPS) Treatment Market Forecast
10.5.2 South Africa Mucopolysaccharidosis (MPS) Treatment Market Forecast
10.5.3 Israel Mucopolysaccharidosis (MPS) Treatment Market Forecast
10.5.4 Turkey Mucopolysaccharidosis (MPS) Treatment Market Forecast
10.5.5 GCC Countries Mucopolysaccharidosis (MPS) Treatment Market Forecast
10.6 Global Mucopolysaccharidosis (MPS) Treatment Forecast by Type (2024-2029)
10.7 Global Mucopolysaccharidosis (MPS) Treatment Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Mucopolysaccharidosis (MPS) Treatment Product Offered
11.1.3 Sanofi Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 Shire (Takeda)
11.2.1 Shire (Takeda) Company Information
11.2.2 Shire (Takeda) Mucopolysaccharidosis (MPS) Treatment Product Offered
11.2.3 Shire (Takeda) Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Shire (Takeda) Main Business Overview
11.2.5 Shire (Takeda) Latest Developments
11.3 BioMarin Pharmaceutical
11.3.1 BioMarin Pharmaceutical Company Information
11.3.2 BioMarin Pharmaceutical Mucopolysaccharidosis (MPS) Treatment Product Offered
11.3.3 BioMarin Pharmaceutical Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 BioMarin Pharmaceutical Main Business Overview
11.3.5 BioMarin Pharmaceutical Latest Developments
11.4 Esteve
11.4.1 Esteve Company Information
11.4.2 Esteve Mucopolysaccharidosis (MPS) Treatment Product Offered
11.4.3 Esteve Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Esteve Main Business Overview
11.4.5 Esteve Latest Developments
11.5 REGENXBIO Inc
11.5.1 REGENXBIO Inc Company Information
11.5.2 REGENXBIO Inc Mucopolysaccharidosis (MPS) Treatment Product Offered
11.5.3 REGENXBIO Inc Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 REGENXBIO Inc Main Business Overview
11.5.5 REGENXBIO Inc Latest Developments
11.6 Sangamo Therapeutics
11.6.1 Sangamo Therapeutics Company Information
11.6.2 Sangamo Therapeutics Mucopolysaccharidosis (MPS) Treatment Product Offered
11.6.3 Sangamo Therapeutics Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Sangamo Therapeutics Main Business Overview
11.6.5 Sangamo Therapeutics Latest Developments
11.7 Ultragenyx Pharmaceutical
11.7.1 Ultragenyx Pharmaceutical Company Information
11.7.2 Ultragenyx Pharmaceutical Mucopolysaccharidosis (MPS) Treatment Product Offered
11.7.3 Ultragenyx Pharmaceutical Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Ultragenyx Pharmaceutical Main Business Overview
11.7.5 Ultragenyx Pharmaceutical Latest Developments
11.8 Abeona Therapeutics
11.8.1 Abeona Therapeutics Company Information
11.8.2 Abeona Therapeutics Mucopolysaccharidosis (MPS) Treatment Product Offered
11.8.3 Abeona Therapeutics Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Abeona Therapeutics Main Business Overview
11.8.5 Abeona Therapeutics Latest Developments
11.9 ArmaGen
11.9.1 ArmaGen Company Information
11.9.2 ArmaGen Mucopolysaccharidosis (MPS) Treatment Product Offered
11.9.3 ArmaGen Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 ArmaGen Main Business Overview
11.9.5 ArmaGen Latest Developments
11.10 Eloxx Pharmaceuticals
11.10.1 Eloxx Pharmaceuticals Company Information
11.10.2 Eloxx Pharmaceuticals Mucopolysaccharidosis (MPS) Treatment Product Offered
11.10.3 Eloxx Pharmaceuticals Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Eloxx Pharmaceuticals Main Business Overview
11.10.5 Eloxx Pharmaceuticals Latest Developments
11.11 Inventiva
11.11.1 Inventiva Company Information
11.11.2 Inventiva Mucopolysaccharidosis (MPS) Treatment Product Offered
11.11.3 Inventiva Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Inventiva Main Business Overview
11.11.5 Inventiva Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Mucopolysaccharidosis (MPS) Treatment Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Stem Cell Therapies
Table 3. Major Players of Enzyme Replacement Therapies
Table 4. Mucopolysaccharidosis (MPS) Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Type (2018-2023)
Table 7. Mucopolysaccharidosis (MPS) Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Application (2018-2023)
Table 10. Global Mucopolysaccharidosis (MPS) Treatment Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Player (2018-2023)
Table 12. Mucopolysaccharidosis (MPS) Treatment Key Players Head office and Products Offered
Table 13. Mucopolysaccharidosis (MPS) Treatment Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Mucopolysaccharidosis (MPS) Treatment Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Regions (2018-2023)
Table 18. Global Mucopolysaccharidosis (MPS) Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Country (2018-2023)
Table 22. Americas Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Type (2018-2023)
Table 24. Americas Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Application (2018-2023)
Table 26. APAC Mucopolysaccharidosis (MPS) Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Region (2018-2023)
Table 28. APAC Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Type (2018-2023)
Table 30. APAC Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Application (2018-2023)
Table 32. Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Country (2018-2023)
Table 34. Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Type (2018-2023)
Table 36. Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Mucopolysaccharidosis (MPS) Treatment
Table 45. Key Market Challenges & Risks of Mucopolysaccharidosis (MPS) Treatment
Table 46. Key Industry Trends of Mucopolysaccharidosis (MPS) Treatment
Table 47. Global Mucopolysaccharidosis (MPS) Treatment Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Mucopolysaccharidosis (MPS) Treatment Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Mucopolysaccharidosis (MPS) Treatment Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Mucopolysaccharidosis (MPS) Treatment Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Sanofi Details, Company Type, Mucopolysaccharidosis (MPS) Treatment Area Served and Its Competitors
Table 52. Sanofi Mucopolysaccharidosis (MPS) Treatment Product Offered
Table 53. Sanofi Mucopolysaccharidosis (MPS) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Sanofi Main Business
Table 55. Sanofi Latest Developments
Table 56. Shire (Takeda) Details, Company Type, Mucopolysaccharidosis (MPS) Treatment Area Served and Its Competitors
Table 57. Shire (Takeda) Mucopolysaccharidosis (MPS) Treatment Product Offered
Table 58. Shire (Takeda) Main Business
Table 59. Shire (Takeda) Mucopolysaccharidosis (MPS) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Shire (Takeda) Latest Developments
Table 61. BioMarin Pharmaceutical Details, Company Type, Mucopolysaccharidosis (MPS) Treatment Area Served and Its Competitors
Table 62. BioMarin Pharmaceutical Mucopolysaccharidosis (MPS) Treatment Product Offered
Table 63. BioMarin Pharmaceutical Main Business
Table 64. BioMarin Pharmaceutical Mucopolysaccharidosis (MPS) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. BioMarin Pharmaceutical Latest Developments
Table 66. Esteve Details, Company Type, Mucopolysaccharidosis (MPS) Treatment Area Served and Its Competitors
Table 67. Esteve Mucopolysaccharidosis (MPS) Treatment Product Offered
Table 68. Esteve Main Business
Table 69. Esteve Mucopolysaccharidosis (MPS) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Esteve Latest Developments
Table 71. REGENXBIO Inc Details, Company Type, Mucopolysaccharidosis (MPS) Treatment Area Served and Its Competitors
Table 72. REGENXBIO Inc Mucopolysaccharidosis (MPS) Treatment Product Offered
Table 73. REGENXBIO Inc Main Business
Table 74. REGENXBIO Inc Mucopolysaccharidosis (MPS) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. REGENXBIO Inc Latest Developments
Table 76. Sangamo Therapeutics Details, Company Type, Mucopolysaccharidosis (MPS) Treatment Area Served and Its Competitors
Table 77. Sangamo Therapeutics Mucopolysaccharidosis (MPS) Treatment Product Offered
Table 78. Sangamo Therapeutics Main Business
Table 79. Sangamo Therapeutics Mucopolysaccharidosis (MPS) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Sangamo Therapeutics Latest Developments
Table 81. Ultragenyx Pharmaceutical Details, Company Type, Mucopolysaccharidosis (MPS) Treatment Area Served and Its Competitors
Table 82. Ultragenyx Pharmaceutical Mucopolysaccharidosis (MPS) Treatment Product Offered
Table 83. Ultragenyx Pharmaceutical Main Business
Table 84. Ultragenyx Pharmaceutical Mucopolysaccharidosis (MPS) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Ultragenyx Pharmaceutical Latest Developments
Table 86. Abeona Therapeutics Details, Company Type, Mucopolysaccharidosis (MPS) Treatment Area Served and Its Competitors
Table 87. Abeona Therapeutics Mucopolysaccharidosis (MPS) Treatment Product Offered
Table 88. Abeona Therapeutics Main Business
Table 89. Abeona Therapeutics Mucopolysaccharidosis (MPS) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Abeona Therapeutics Latest Developments
Table 91. ArmaGen Details, Company Type, Mucopolysaccharidosis (MPS) Treatment Area Served and Its Competitors
Table 92. ArmaGen Mucopolysaccharidosis (MPS) Treatment Product Offered
Table 93. ArmaGen Main Business
Table 94. ArmaGen Mucopolysaccharidosis (MPS) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. ArmaGen Latest Developments
Table 96. Eloxx Pharmaceuticals Details, Company Type, Mucopolysaccharidosis (MPS) Treatment Area Served and Its Competitors
Table 97. Eloxx Pharmaceuticals Mucopolysaccharidosis (MPS) Treatment Product Offered
Table 98. Eloxx Pharmaceuticals Main Business
Table 99. Eloxx Pharmaceuticals Mucopolysaccharidosis (MPS) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Eloxx Pharmaceuticals Latest Developments
Table 101. Inventiva Details, Company Type, Mucopolysaccharidosis (MPS) Treatment Area Served and Its Competitors
Table 102. Inventiva Mucopolysaccharidosis (MPS) Treatment Product Offered
Table 103. Inventiva Mucopolysaccharidosis (MPS) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. Inventiva Main Business
Table 105. Inventiva Latest Developments
Table 1. Mucopolysaccharidosis (MPS) Treatment Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Stem Cell Therapies
Table 3. Major Players of Enzyme Replacement Therapies
Table 4. Mucopolysaccharidosis (MPS) Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Type (2018-2023)
Table 7. Mucopolysaccharidosis (MPS) Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Application (2018-2023)
Table 10. Global Mucopolysaccharidosis (MPS) Treatment Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Player (2018-2023)
Table 12. Mucopolysaccharidosis (MPS) Treatment Key Players Head office and Products Offered
Table 13. Mucopolysaccharidosis (MPS) Treatment Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Mucopolysaccharidosis (MPS) Treatment Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Regions (2018-2023)
Table 18. Global Mucopolysaccharidosis (MPS) Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Country (2018-2023)
Table 22. Americas Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Type (2018-2023)
Table 24. Americas Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Application (2018-2023)
Table 26. APAC Mucopolysaccharidosis (MPS) Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Region (2018-2023)
Table 28. APAC Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Type (2018-2023)
Table 30. APAC Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Application (2018-2023)
Table 32. Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Country (2018-2023)
Table 34. Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Type (2018-2023)
Table 36. Europe Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Mucopolysaccharidosis (MPS) Treatment
Table 45. Key Market Challenges & Risks of Mucopolysaccharidosis (MPS) Treatment
Table 46. Key Industry Trends of Mucopolysaccharidosis (MPS) Treatment
Table 47. Global Mucopolysaccharidosis (MPS) Treatment Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Mucopolysaccharidosis (MPS) Treatment Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Mucopolysaccharidosis (MPS) Treatment Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Mucopolysaccharidosis (MPS) Treatment Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Sanofi Details, Company Type, Mucopolysaccharidosis (MPS) Treatment Area Served and Its Competitors
Table 52. Sanofi Mucopolysaccharidosis (MPS) Treatment Product Offered
Table 53. Sanofi Mucopolysaccharidosis (MPS) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Sanofi Main Business
Table 55. Sanofi Latest Developments
Table 56. Shire (Takeda) Details, Company Type, Mucopolysaccharidosis (MPS) Treatment Area Served and Its Competitors
Table 57. Shire (Takeda) Mucopolysaccharidosis (MPS) Treatment Product Offered
Table 58. Shire (Takeda) Main Business
Table 59. Shire (Takeda) Mucopolysaccharidosis (MPS) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Shire (Takeda) Latest Developments
Table 61. BioMarin Pharmaceutical Details, Company Type, Mucopolysaccharidosis (MPS) Treatment Area Served and Its Competitors
Table 62. BioMarin Pharmaceutical Mucopolysaccharidosis (MPS) Treatment Product Offered
Table 63. BioMarin Pharmaceutical Main Business
Table 64. BioMarin Pharmaceutical Mucopolysaccharidosis (MPS) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. BioMarin Pharmaceutical Latest Developments
Table 66. Esteve Details, Company Type, Mucopolysaccharidosis (MPS) Treatment Area Served and Its Competitors
Table 67. Esteve Mucopolysaccharidosis (MPS) Treatment Product Offered
Table 68. Esteve Main Business
Table 69. Esteve Mucopolysaccharidosis (MPS) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Esteve Latest Developments
Table 71. REGENXBIO Inc Details, Company Type, Mucopolysaccharidosis (MPS) Treatment Area Served and Its Competitors
Table 72. REGENXBIO Inc Mucopolysaccharidosis (MPS) Treatment Product Offered
Table 73. REGENXBIO Inc Main Business
Table 74. REGENXBIO Inc Mucopolysaccharidosis (MPS) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. REGENXBIO Inc Latest Developments
Table 76. Sangamo Therapeutics Details, Company Type, Mucopolysaccharidosis (MPS) Treatment Area Served and Its Competitors
Table 77. Sangamo Therapeutics Mucopolysaccharidosis (MPS) Treatment Product Offered
Table 78. Sangamo Therapeutics Main Business
Table 79. Sangamo Therapeutics Mucopolysaccharidosis (MPS) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Sangamo Therapeutics Latest Developments
Table 81. Ultragenyx Pharmaceutical Details, Company Type, Mucopolysaccharidosis (MPS) Treatment Area Served and Its Competitors
Table 82. Ultragenyx Pharmaceutical Mucopolysaccharidosis (MPS) Treatment Product Offered
Table 83. Ultragenyx Pharmaceutical Main Business
Table 84. Ultragenyx Pharmaceutical Mucopolysaccharidosis (MPS) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Ultragenyx Pharmaceutical Latest Developments
Table 86. Abeona Therapeutics Details, Company Type, Mucopolysaccharidosis (MPS) Treatment Area Served and Its Competitors
Table 87. Abeona Therapeutics Mucopolysaccharidosis (MPS) Treatment Product Offered
Table 88. Abeona Therapeutics Main Business
Table 89. Abeona Therapeutics Mucopolysaccharidosis (MPS) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Abeona Therapeutics Latest Developments
Table 91. ArmaGen Details, Company Type, Mucopolysaccharidosis (MPS) Treatment Area Served and Its Competitors
Table 92. ArmaGen Mucopolysaccharidosis (MPS) Treatment Product Offered
Table 93. ArmaGen Main Business
Table 94. ArmaGen Mucopolysaccharidosis (MPS) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. ArmaGen Latest Developments
Table 96. Eloxx Pharmaceuticals Details, Company Type, Mucopolysaccharidosis (MPS) Treatment Area Served and Its Competitors
Table 97. Eloxx Pharmaceuticals Mucopolysaccharidosis (MPS) Treatment Product Offered
Table 98. Eloxx Pharmaceuticals Main Business
Table 99. Eloxx Pharmaceuticals Mucopolysaccharidosis (MPS) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Eloxx Pharmaceuticals Latest Developments
Table 101. Inventiva Details, Company Type, Mucopolysaccharidosis (MPS) Treatment Area Served and Its Competitors
Table 102. Inventiva Mucopolysaccharidosis (MPS) Treatment Product Offered
Table 103. Inventiva Mucopolysaccharidosis (MPS) Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. Inventiva Main Business
Table 105. Inventiva Latest Developments
LIST OF FIGURES
Figure 1. Mucopolysaccharidosis (MPS) Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Mucopolysaccharidosis (MPS) Treatment Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Mucopolysaccharidosis (MPS) Treatment Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Mucopolysaccharidosis (MPS) Treatment Sales Market Share by Country/Region (2022)
Figure 8. Mucopolysaccharidosis (MPS) Treatment Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Type in 2022
Figure 10. Mucopolysaccharidosis (MPS) Treatment in Hospitals
Figure 11. Global Mucopolysaccharidosis (MPS) Treatment Market: Hospitals (2018-2023) & ($ Millions)
Figure 12. Mucopolysaccharidosis (MPS) Treatment in Clinics
Figure 13. Global Mucopolysaccharidosis (MPS) Treatment Market: Clinics (2018-2023) & ($ Millions)
Figure 14. Mucopolysaccharidosis (MPS) Treatment in Homecare
Figure 15. Global Mucopolysaccharidosis (MPS) Treatment Market: Homecare (2018-2023) & ($ Millions)
Figure 16. Global Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Application in 2022
Figure 17. Global Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Player in 2022
Figure 18. Global Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Mucopolysaccharidosis (MPS) Treatment Market Size 2018-2023 ($ Millions)
Figure 20. APAC Mucopolysaccharidosis (MPS) Treatment Market Size 2018-2023 ($ Millions)
Figure 21. Europe Mucopolysaccharidosis (MPS) Treatment Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size 2018-2023 ($ Millions)
Figure 23. Americas Mucopolysaccharidosis (MPS) Treatment Value Market Share by Country in 2022
Figure 24. United States Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Region in 2022
Figure 29. APAC Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Type in 2022
Figure 30. APAC Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Application in 2022
Figure 31. China Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Country in 2022
Figure 38. Europe Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Type (2018-2023)
Figure 39. Europe Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Application (2018-2023)
Figure 40. Germany Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 54. APAC Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 55. Europe Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 57. United States Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 58. Canada Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 61. China Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 62. Japan Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 63. Korea Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 65. India Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 66. Australia Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 67. Germany Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 68. France Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 69. UK Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 70. Italy Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 71. Russia Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 72. Spain Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 75. Israel Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 78. Global Mucopolysaccharidosis (MPS) Treatment Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Mucopolysaccharidosis (MPS) Treatment Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Mucopolysaccharidosis (MPS) Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Mucopolysaccharidosis (MPS) Treatment Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Mucopolysaccharidosis (MPS) Treatment Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Mucopolysaccharidosis (MPS) Treatment Sales Market Share by Country/Region (2022)
Figure 8. Mucopolysaccharidosis (MPS) Treatment Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Type in 2022
Figure 10. Mucopolysaccharidosis (MPS) Treatment in Hospitals
Figure 11. Global Mucopolysaccharidosis (MPS) Treatment Market: Hospitals (2018-2023) & ($ Millions)
Figure 12. Mucopolysaccharidosis (MPS) Treatment in Clinics
Figure 13. Global Mucopolysaccharidosis (MPS) Treatment Market: Clinics (2018-2023) & ($ Millions)
Figure 14. Mucopolysaccharidosis (MPS) Treatment in Homecare
Figure 15. Global Mucopolysaccharidosis (MPS) Treatment Market: Homecare (2018-2023) & ($ Millions)
Figure 16. Global Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Application in 2022
Figure 17. Global Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Player in 2022
Figure 18. Global Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Mucopolysaccharidosis (MPS) Treatment Market Size 2018-2023 ($ Millions)
Figure 20. APAC Mucopolysaccharidosis (MPS) Treatment Market Size 2018-2023 ($ Millions)
Figure 21. Europe Mucopolysaccharidosis (MPS) Treatment Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size 2018-2023 ($ Millions)
Figure 23. Americas Mucopolysaccharidosis (MPS) Treatment Value Market Share by Country in 2022
Figure 24. United States Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Region in 2022
Figure 29. APAC Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Type in 2022
Figure 30. APAC Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Application in 2022
Figure 31. China Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Country in 2022
Figure 38. Europe Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Type (2018-2023)
Figure 39. Europe Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Application (2018-2023)
Figure 40. Germany Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Mucopolysaccharidosis (MPS) Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 54. APAC Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 55. Europe Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 57. United States Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 58. Canada Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 61. China Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 62. Japan Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 63. Korea Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 65. India Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 66. Australia Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 67. Germany Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 68. France Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 69. UK Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 70. Italy Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 71. Russia Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 72. Spain Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 75. Israel Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Mucopolysaccharidosis (MPS) Treatment Market Size 2024-2029 ($ Millions)
Figure 78. Global Mucopolysaccharidosis (MPS) Treatment Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Mucopolysaccharidosis (MPS) Treatment Market Size Market Share Forecast by Application (2024-2029)
